Vijay Kuchroo, D.V.M., Ph.D.

Samuel L. Wasserstrom Professor of Neurology, Harvard Medical School
Senior Scientist, Neurology, Brigham and Women’s Hospital
Associate Member, Broad Institute
Director, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston

Vijay is Professor of Neurology at Harvard Medical School, an associate member of the Broad Institute and a participant in the Klarman Cell Observatory. An established leader in immunology, he was the first to describe the inhibitory receptor TIM-3, which is being exploited as a target for cancer immunotherapy, and the first to describe the development of highly pathogenic Th17 cells, which have been shown to induce multiple different autoimmune diseases in humans.